QCM
ANRO icon

Quantinno Capital Management’s Alto Neuroscience ANRO Stock Holding History

Quantinno Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
38,556
+2,487
+7% +$57.5K ﹤0.01% 2547
2026
Q1 		$811K Buy
36,069
+490
+1% +$9.08K ﹤0.01% 2344
2025
Q4 		$633K Hold
35,579
– – ﹤0.01% 2183
2025
Q3 		$143K Hold
35,579
– – ﹤0.01% 2840
2025
Q2 		$78.3K Buy
+35,579
New +$84.7K ﹤0.01% 2534

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Quantinno Capital Management's ANRO Position: Q2 2026 in Review

Quantinno Capital Management increased its Alto Neuroscience (ANRO) stake by 6.9% in Q2 2026, buying an estimated $57.5K and bringing the position to 38,556 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Quantinno Capital Management first reported a position in ANRO in Q2 2025 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Quantinno Capital Management held 38,556 shares of Alto Neuroscience worth $1.02M as of Q2 2026.
  • Quantinno Capital Management bought 2,487 Alto Neuroscience shares in Q2 2026, an estimated $57.5K.
  • Alto Neuroscience made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2547 holding.
  • Quantinno Capital Management first reported a position in Alto Neuroscience in Q2 2025 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.